Comparative Pharmacology
Head-to-head clinical analysis: MEMBRANEBLUE versus VISIONBLUE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MEMBRANEBLUE versus VISIONBLUE.
MEMBRANEBLUE vs VISIONBLUE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Methylene blue (Membraneblue) is a selective inhibitor of guanylyl cyclase, thereby reducing cyclic guanosine monophosphate (cGMP) levels. It also acts as an electron carrier in the reduction of methemoglobin to hemoglobin.
Visionblue (trypan blue) is a dye that selectively stains the anterior lens capsule and vitreous, enhancing visualization during ophthalmic surgeries such as cataract extraction and vitrectomy. It does not exert pharmacological activity but acts as a vital stain.
2 mg/kg intravenously once, administered over 30 minutes; may repeat once if clinically indicated after 30 minutes.
0.5 mL of 0.025% solution intracameral injection (single use).
None Documented
None Documented
Terminal elimination half-life 2.5-3.5 hours in adults; prolonged in hepatic or renal impairment (up to 6-8 hours).
Approximately 2.5 hours in patients with normal renal function; prolonged in renal impairment (up to 12 hours).
Renal: approximately 60-70% unchanged; biliary/fecal: 20-30% as conjugated metabolites; minor pulmonary excretion.
Primarily eliminated unchanged via renal glomerular filtration; minimal biliary excretion (<5%).
Category C
Category C
Ophthalmic Dye
Ophthalmic Dye/Stain